Covaxin gets shelf life extension up to 12 months

Vaccine maker Bharat Biotech on Wednesday said the Central Drugs Standard Control Organisation (CDSCO) has approved the extension of shelf life of its COVID-19 vaccine Covaxin up to 12 months from the date of manufacture.

migrator

Published:3rd Nov, 2021 at 4:07 PM

New Delhi

"The CDSCO has approved the extension of shelf life of Covaxin up to 12 months, from the date of manufacture. This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO," Bharat Biotech said in a tweet.

The shelf life extension has been communicated to "our stakeholders," it added.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Covaxin gets shelf life extension up to 12 months

Vaccine maker Bharat Biotech on Wednesday said the Central Drugs Standard Control Organisation (CDSCO) has approved the extension of shelf life of its COVID-19 vaccine Covaxin up to 12 months from the date of manufacture.

Also Read

Anbumani removes GK Mani from PMK

Vijay leaves for Malaysia ahead of 'Jana Nayagan' audio launch

Offering milk, flowers to sea, silent processions mark 21st Tsunami anniversary in TN

Chennai Police arrest man for Rs 20 Lakh apartment lease scam

South Korea: Special counsel seeks 10-year prison term for ex-President Yoon over obstruction of justice, other charges